REGN Sentiment Analysis
We collect and analyze sentiment surrounding REGN stock to help you make informed investment decisions.
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 25.34% Profit Margin: A Victory for QuantWave
Published on May 9, 2025
REGENERON PHARMACEUTICALS, INC....
QuantWave Forecast Achieves 24.9% Profit Target for Regeneron Pharmaceuticals, Inc. Stock
Published on May 9, 2025
Regeneron Pharmaceuticals, Inc....
REGENERON PHARMACEUTICALS, INC. Stock Hits Forecast Price Target with a Profit of 24.47%
Published on May 9, 2025
On February 28, 2025, QuantWave's forecasting system signaled a short position for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 25.34% Profit
Published on May 9, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Stock Hits QuantWave's Price Target with 24.9% Profit
Published on May 9, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Achieves Forecast Price Target with a Profit of 24.47%
Published on May 9, 2025
REGENERON PHARMACEUTICALS, INC. stock recently hit the forecast price target set by QuantWave on May 9, 2025....
Regeneron Pharmaceuticals Receives Dupixent Approval in Japan
Published on April 12, 2025
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has recently received approval for its drug Dupixent in Japan....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.79% Profit: QuantWave's Success
Published on April 10, 2025
REGENERON PHARMACEUTICALS, INC....
Regeneron Pharmaceuticals, Inc. Stock Hits Short-Term Price Target with 17.79% Profit as Forecasted by QuantWave
Published on April 10, 2025
Regeneron Pharmaceuticals, Inc....
REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis
Published on April 8, 2025
In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 23.04% Profit
Published on April 8, 2025
On February 25, 2025, QuantWave, an automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Short Forecast Target with 20.49% Profit
Published on April 8, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 20.0% Profit, Validating QuantWave's Analytics
Published on April 8, 2025
REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast, signaling a 20....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 23.04% Profit
Published on April 8, 2025
On February 25, 2025, QuantWave, an automated forecasting platform, issued a short direction forecast signal for REGENERON PHARMACEUTICALS, INC. with a price target of 555.15 $. The stock had been trading at 721.31 $ at the time of the signal, and on...
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 20.49% Profit for QuantWave Users
Published on April 8, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit
Published on April 4, 2025
QuantWave's forecast for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast with 16.34% Profit: QuantWave Analysis
Published on April 4, 2025
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56%
Published on April 4, 2025
REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....
REGENERON PHARMACEUTICALS, INC. Stock Hits QuantWave's Price Target Forecast with a Profit of 17.34%
Published on April 4, 2025
On January 23, 2025, QuantWave, the automated forecasting platform, issued a short forecast signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at 692.73 $. This prediction proved to be accurate as the target price of 572.6 $ was rea...
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit
Published on April 4, 2025
QuantWave, an automated forecasting platform, successfully predicted the short movement for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with a Profit of 17.63%
Published on April 4, 2025
REGENERON PHARMACEUTICALS, INC. stock successfully reached the price target forecasted by QuantWave on April 4, 2025....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 15.56% Profit
Published on April 4, 2025
REGENERON PHARMACEUTICALS, INC. stock reached the forecasted target price of 571....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast on QuantWave with 16.34% Profit
Published on April 4, 2025
On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit
Published on April 4, 2025
REGENERON PHARMACEUTICALS, INC. stock has successfully reached the price target forecast set by QuantWave on April 4, 2025....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.63% Profit: QuantWave Analysis
Published on April 4, 2025
REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, yielding a profit of 17.63%....